In acute promyelocytic leukemia (APL), the typical t(15;17) and the rare t(11;17) translocations express, respectively, the PML͞RAR␣ and PLZF͞RAR␣ fusion proteins (where RAR␣ is retinoic acid receptor ␣). Herein, we demonstrate that the PLZF and PML proteins interact with each other and colocalize onto nuclear bodies (NBs). Furthermore, induction of PML expression by interferons leads to a recruitment of PLZF onto NBs without increase in the levels of the PLZF protein. PML͞RAR␣ and PLZF͞RAR␣ localize to the same microspeckled nuclear domains that appear to be common targets for the two fusion proteins in APL. Although PLZF͞RAR␣ does not affect the localization of PML, PML͞ RAR␣ delocalizes the endogenous PLZF protein in t(15;17)-positive NB4 cells, pointing to a hierarchy in the nuclear targeting of these proteins. Thus, our results unify the molecular pathogenesis of APL with at least two different RAR␣ gene translocations and stress the importance of alterations of PLZF and RAR␣ nuclear localizations in this disease.Acute promyelocytic leukemia (APL) represents approximately 10% of all adult acute myeloid leukemias (1). The molecular pathogenesis of APL is, at least in part, associated with the disruption of the retinoic acid receptor ␣ (RAR␣) gene through its fusion to one of four different loci (2-7). These translocations result in the expression of chimeric RAR␣ fusion proteins that retain the DNA and ligand binding domains of the receptor and gain a dimerization domain from the fusion partner. Paradoxically, APL is the first human malignancy that may undergo complete remission in response to differentiation therapy with all-trans-retinoic acid (RA). The molecular basis of these remissions is still disputed.The majority of APL cases, and all cases that consistently respond to RA treatment, possess the t(15;17) translocation that fuses the PML and RAR␣ genes (3,(8)(9)(10)(11)(12). PML is a member of a functionally diverse gene family that encodes proteins characterized by the presence of a N-terminal C 3 HC 4 RING-finger motif (13), followed by one or two cysteine-rich regions (B boxes) and a coiled-coil protein dimerization interface. The function of PML is unknown, but up-regulation of its expression by interferons (IFNs) (14-16) and its negative effect on cell growth and cellular transformation by cooperating oncogenes (17-19) suggest a role in growth control. The product of the wild-type PML gene is a phosphoprotein (20) that localizes both in the nucleoplasm and in the specific multiprotein structures called PML nuclear bodies (NBs) (20-24). The PML͞RAR␣ fusion protein, which is expressed in APL cells as a result of t(15;17), contains all predicted PML structural motifs and is able to delocalize the wild-type PML and other NB components onto discrete microspeckled nuclear structures (21-24). It is still unclear which role, if any, disruption of NBs and͞or establishment of microspeckled structures play in cellular transformation. Nevertheless, complete restoration of NBs upon RA treatment in NB4 ...
This study suggests that the unavoidable spatial inhomogeneity of intense electromagnetic fields has a drastic effect on the electron-positron pair creation process from the vacuum. We use the example of the Breit-Wheeler process, where the collision of two gamma-ray photons is predicted to create electron-positron pairs, to show that the multi-photon pair creation process cannot be modeled by solutions to the Dirac equation under time-periodic fields that are spatially homogeneous. The neglect of the spatial inhomogeneity leads here to spurious energy spectra and misleading pair creation yields that can be incorrect by up to several orders in magnitude. This finding is surprising as there are many widely cited works where the laser is modeled by a spatially homogeneous alternating electric field.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.